Cold Atmospheric Plasma (CAP) is one of the fastest-growing physical therapy technologies in the biomedical field. Unlike traditional thermal plasma, CAP generates a rich cocktail of bioactive species for tissue repair while operating at temperatures close to the animal's own body temperature — hence the name "cold" plasma. In veterinary medicine, CAP is primarily delivered through two technical approaches: gas-jet cold plasma (using inert gases such as helium or argon as the discharge medium, applied precisely through a nozzle to targeted tissues) and dielectric barrier discharge (DBD, which uses an insulating layer between electrodes and is well suited for large-area surface treatment). Among these, gas-jet cold plasma is considered the more clinically promising route due to its precision targeting, adjustable parameters, and superior penetration of reactive species into tissue.
Mechanisms of Action of Cold Plasma
Whether delivered via gas jet or DBD, the core biological effects of cold plasma stem from the diverse reactive species it generates at atmospheric pressure:
- Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS) — potent antimicrobial action that disrupts bacterial cell membranes
- Charged particles and electric fields — promote cell migration and tissue regeneration
- Ultraviolet radiation — provides auxiliary sterilization
- Excited gas molecules — helium/argon plasma generates specific reactive species with enhanced tissue penetration and targeting capability
Gas-jet CAP offers precise control over the type and concentration of reactive species by adjusting gas type (helium/argon), flow rate, power, and nozzle distance, enabling personalized treatment protocols. DBD, on the other hand, is structurally simpler and covers larger areas, making it ideal for rapid treatment of superficial wounds. The two approaches complement each other in clinical practice.[2]
Key Research Findings in Veterinary Medicine
Cold Plasma and Wound Healing
Wound healing is the most extensively studied application of CAP. In human medicine, numerous clinical trials have confirmed the efficacy of gas-jet CAP (using helium/argon) for chronic wounds, diabetic foot ulcers, and burn injuries. In veterinary medicine, preliminary studies indicate that CAP treatment significantly accelerates the healing of both acute and chronic wounds in dogs and cats. A study on chronic wounds in canines showed that the group receiving cold plasma therapy demonstrated significantly faster wound closure and higher-quality tissue regeneration compared to the control group.[3]
Antimicrobial Action and Skin Inflammation
Cold plasma exhibits broad-spectrum killing efficacy against common pet skin pathogens, including Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, and others. The unique advantage of gas-jet CAP lies in its ability to deliver reactive species with precision into challenging anatomical sites such as skin folds, interdigital spaces, and ear canals — areas where conventional topical medications often struggle to reach effectively. Research also indicates that CAP works synergistically with antibiotics, potentially reducing the required antibiotic dosage.[4]
DBD Technology: A Portable and Efficient Complement
Dielectric Barrier Discharge (DBD), the other major technical pathway for cold plasma, offers unique value in veterinary practice. DBD features large electrode area, simple construction, lower cost, and excellent portability, making it particularly well suited for post-surgical incision disinfection and daily at-home care. Studies show that DBD plasma treatment reduces wound bacterial load and promotes superficial angiogenesis. In DGE's product ecosystem, DBD technology is primarily integrated into the Handheld WCare device, serving as a portable complement to the Cold Ion Therapy device (gas-jet CAP). This pairing delivers full-scenario coverage: precision clinical treatment plus daily home care.
FDA Clearance and Technology Translation
The U.S. FDA has authorized multiple cold plasma medical devices through the De Novo classification pathway, with gas-jet cold plasma devices representing the mainstream approved technology.[5] DGE Pet's core cold plasma technology is derived from this FDA-cleared medical framework, and has been developed into two product lines: the Cold Ion Therapy device (gas-jet CAP, helium/argon medium, for clinical precision treatment) and the Handheld WCare device (DBD technology, for portable daily care), covering the full spectrum from professional veterinary hospital use to at-home rehabilitation.
Future Directions
As cold plasma research in veterinary medicine continues to advance, several areas deserve close attention: species-specific optimization of gas-jet CAP parameters (tailoring helium/argon ratios and treatment protocols for different animal species and conditions), broader deployment of portable CAP devices in veterinary clinics, and the execution of large-scale randomized controlled trials. Gas-jet CAP has accumulated decades of clinical experience in human medicine, particularly in Europe and Asia, and its application in veterinary medicine is now transitioning from the "technology introduction phase" to the "standards establishment phase." Cold Atmospheric Plasma Medicine (CAM), as an emerging interdisciplinary field, is redefining the boundaries of physical therapy for animals — guided by the principle that technology should be gentle.
